Proteomic Profiling of Thyroid Papillary Carcinoma

被引:13
作者
Ban, Yoshiyuki [1 ]
Yamamoto, Gou [2 ]
Takada, Michiya [1 ]
Hayashi, Shigeo [2 ]
Ban, Yoshio [3 ]
Shimizu, Kazuo [4 ]
Akasu, Haruki [4 ]
Igarashi, Takehito [4 ]
Bando, Yasuhiko [5 ]
Tachikawa, Tetsuhiko [2 ,6 ]
Hirano, Tsutomu [1 ]
机构
[1] Showa Univ, Sch Med, Div Diabet Metab & Endocrinol, Dept Med,Shinagawa Ku, 1-5-8 Hatanodai, Tokyo 1428666, Japan
[2] Showa Univ, Sch Dent, Dept Oral Pathol & Diag, Shinagawa Ku, Tokyo 1428555, Japan
[3] Ban Thyroid Clin, Megro Ku, Tokyo 1520035, Japan
[4] Nippon Med Sch, Dept Surg, Div Endocrine Surg, Bunkyo Ku, Tokyo 1138602, Japan
[5] Biosys Technol Inc, Meguro Ku, Tokyo 1520031, Japan
[6] Showa Univ, Comprehens Res Ctr Oral Canc, Shinagawa Ku, Tokyo 1428555, Japan
关键词
D O I
10.1155/2012/815079
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Papillary thyroid carcinoma (PTC) is the most common endocrine malignancy. We performed shotgun liquid chromatography (LC)/tandem mass spectrometry (MS/MS) analysis on pooled protein extracts from patients with PTC and compared the results with those from normal thyroid tissue validated by real-time (RT) PCR and immunohistochemistry (IHC). We detected 524 types of protein in PTC and 432 in normal thyroid gland. Among these proteins, 145 were specific to PTC and 53 were specific to normal thyroid gland. We have also identified two important new markers, nephronectin (NPNT) and malectin (MLEC). Reproducibility was confirmed with several known markers, but the one of two new candidate markers such as MLEC did not show large variations in expression levels. Furthermore, IHC confirmed the overexpression of both those markers in PTCs compared with normal surrounding tissues. Our protein data suggest that NPNT and MLEC could be a characteristic marker for PTC.
引用
收藏
页数:7
相关论文
共 22 条
[1]   N-glycan structures: recognition and processing in the ER [J].
Aebi, Markus ;
Bernasconi, Riccardo ;
Clerc, Simone ;
Molinari, Maurizio .
TRENDS IN BIOCHEMICAL SCIENCES, 2010, 35 (02) :74-82
[2]   Identification and characterization of a novel extracellular matrix protein nephronectin that is associated with integrin α8β1 in the embryonic kidney [J].
Brandenberger, R ;
Schmidt, A ;
Linton, J ;
Wang, D ;
Backus, C ;
Denda, S ;
Müller, U ;
Reichardt, LF .
JOURNAL OF CELL BIOLOGY, 2001, 154 (02) :447-458
[3]   A preoperative diagnostic test that distinguishes benign from malignant thyroid carcinoma based on gene expression [J].
Cerutti, JM ;
Delcelo, R ;
Amadei, MJ ;
Nakabashi, C ;
Maciel, RMB ;
Peterson, B ;
Shoemaker, J ;
Riggins, GJ .
JOURNAL OF CLINICAL INVESTIGATION, 2004, 113 (08) :1234-1242
[4]  
Eckhardt BL, 2005, MOL CANCER RES, V3, P1
[5]   Perspectives and limitations of microarray-based gene expression profiling of thyroid tumors [J].
Eszlinger, Markus ;
Krohn, Knut ;
Kukulska, Aleksandra ;
Jarzab, Barbara ;
Paschke, Ralf .
ENDOCRINE REVIEWS, 2007, 28 (03) :322-338
[6]   Editorial:: Challenging dogma in thyroid cancer molecular genetics -: Role of RET/PTC and BRAF in tumor initiation [J].
Fagin, JA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (09) :4264-4266
[8]   Molecular profiling distinguishes papillary carcinoma from benign thyroid nodules [J].
Finley, DJ ;
Arora, N ;
Zhu, BX ;
Gallagher, L ;
Fahey, TJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (07) :3214-3223
[9]   Malectin Participates in a Backup Glycoprotein Quality Control Pathway in the Mammalian ER [J].
Galli, Carmela ;
Bernasconi, Riccardo ;
Solda, Tatiana ;
Calanca, Verena ;
Molinari, Maurizio .
PLOS ONE, 2011, 6 (01)
[10]   Old and New Insights in the Treatment of Thyroid Carcinoma [J].
Gasent Blesa, Joan Manel ;
Grande Pulido, Enrique ;
Provencio Pulla, Mariano ;
Alberola Candel, Vicente ;
Laforga Canales, Juan Bautista ;
Grimalt Arrom, Miguel ;
Martin Rico, Patricia .
JOURNAL OF THYROID RESEARCH, 2010, 2010